v3.26.1
Income taxes
12 Months Ended
Dec. 31, 2025
Income taxes  
Income taxes

17.

Income taxes:

(a)

The Companys income tax provision differs from that calculated by applying the combined enacted Canadian federal and provincial statutory income tax rate of 27% for the year ended December 31, 2025 (2024 - 27%) as follows:

Year ended December 31 

 

  ​ ​ ​

2025

  ​ ​ ​

2024

 

Income (loss) before income taxes:

 

  ​

 

  ​

Domestic

 

(32,205)

 

Foreign

 

909

 

Total

$

(31,296)

$

(57,775)

Statutory tax rate

 

27.0

%  

 

27.0

%

Tax recovery

$

(8,450)

$

(15,599)

Increase (decrease) in income tax resulting from:

 

  ​

 

  ​

Non-deductible expenses and permanent differences:

 

 

1,045

Share-based compensation

 

2,565

 

SIF contribution liabilities

 

3,153

 

Change in fair value of SAFE liabilities

 

2,708

 

Change in fair value of Convertible Notes

 

(5,932)

 

Warrant consideration

 

520

 

Other

 

(241)

 

Adjustment for prior years

 

(59)

 

(140)

Tax rate differences – foreign & domestic

 

(12)

 

679

Non-refundable federal income tax credits

 

 

(22)

Impact of foreign exchange differentials and other

 

359

 

18

Changes in valuation allowance

 

5,463

 

14,014

Income tax (recovery) expense

$

74

$

(5)

(b)

The significant components of the deferred income tax assets, presented in long-term other assets on the consolidated balance sheets, are as follows:

As of December 31

  ​ ​ ​

2025

  ​ ​ ​

2024

Deferred income tax assets:

 

  ​

 

  ​

Net operating tax loss carry-forwards

$

54,356

$

47,884

Property and equipment and other

 

5,414

 

4,038

Research and development expenditures

 

13,846

 

13,205

Federal and provincial investment tax credits

 

7,487

 

7,140

Other

 

1,739

 

2,954

Total gross deferred income tax assets

 

82,842

 

75,221

Valuation allowance

 

(82,817)

 

(75,115)

Total deferred income tax assets

$

25

$

106

ASC 740 requires that the tax benefit of net operating losses, temporary differences and credit carryforwards be recorded as an asset to the extent that management assesses that realization is more likely than not. The ultimate realization of deferred income tax assets is dependent on the generation of sufficient taxable income during the future periods in which those temporary differences are expected to reverse. If the evidence does not exist that the deferred income tax assets will be fully realized, a valuation allowance has been provided.

17.

Income taxes: (continued)

(c)

The Company has non-capital loss-carry forwards to offset future taxable income that expire as follows:

  ​ ​ ​

  ​ ​ ​

United

Non-capital loss carry forwards

Canada

Kingdom

2026

$

23

$

2027

 

245

 

2028

 

353

 

2029

 

786

 

2030

 

1,354

 

2031

 

1,872

 

2032

 

2,306

 

2033

 

2,406

 

2034

 

2,613

 

2035

 

2,459

 

2036

 

4,463

 

2037

 

5,500

 

2038

 

6,134

 

2039

 

7,447

 

2040

 

16,438

 

2041

 

15,405

 

2042

 

38,314

 

2043

 

30,289

 

2044

 

26,633

 

2045

 

15,740

 

Indefinite

 

 

22,182

$

180,780

$

22,182

The Companys pool of deductible Scientific Research & Experimental Development expenditures at December 31, 2025 was $51,300 (CAD 70,308), and $48,905 (CAD 70,308) at December 31, 2024. These expenditures are available to offset future taxable income and have no expiry date.

The Company has investment tax credits of approximately $9,433 (CAD 12,929) as of December 31, 2025, and $8,993 (CAD 12,929) as of December 31, 2024. The investment tax credits will expire between 2028 and 2041 and are available to be applied against future Canadian federal and provincial income taxes payable.